Skip to main content

Table 1 Demographic and surgical presentation of the included patients

From: The salutary effect of peritoneal dialysis catheters on enhanced recovery among high-risk pediatric patients undergoing the left coronary transfer procedure: a cohort study

  Total (n = 84) No PDC (n = 67) PDC (n = 17) P
Demographics
  Age at surgery, months, median (IQR) 12.5 (7.0, 40.5) 20.0 (8.0, 55.0) 6 (3, 11.0) < 0.001
  4–12 months, n (%) 30 (35.7) 21 (31.3) 9 (52.9)  
  ≤ 4 months, n (%) 12 (14.3) 6 (9.0) 6 (35.3)  
  Male, n (%) 49 (58.3) 42 (62.7) 7 (41.2) 0.108
  Weight, kg, median (IQR) 9.0 (6.5, 14.0) 11.0 (7.7, 16.5) 6.0 (5.65, 7.40) < 0.001
  LVEF, %, median (IQR) 55.0 (25.0, 65.8) 60.0 (37.0, 68.0) 18.0 (15.9, 22.5) < 0.001
  LVEF ≤50%, n (%) 42 (50.0) 23(34.3) 17(100) < 0.001
  LVEF ≤25%, n (%) 23 (27.4) 9 (13.4) 14 (82.4)  
  LVEDD, mm, median (IQR) 40.5 (36.3, 45.0) 40.0 (37.0, 45.0) 41.0 (35.5, 46.0) 0.668
Mitral regurgitation, n (%)     0.121
  None/trivial 21 (25.0) 16 (23.9) 5(29.4)  
  Mild 21 (25.0) 15(22.4) 6(35.3)  
  Moderate 20 (23.8) 15(22.4) 5(29.4)  
  Severe 22 (26.2) 21(31.3) 1(5.9)  
  Serum creatinine, mg/dL, median (IQR) 0.31 (0.26, 0.40) 0.31 (0.27, 0.41) 0.32 (0.22, 0.35) 0.28
  Albumin, g/dL, mean (SD) 43.9 ± 3.1 44.0 ± 3.3 43.9 ± 2.4 0.932
  CK-MB, U/L, median (IQR) 25.0 (19.3, 35.0) 24.0 (19.0, 33.0) 38.0 (23.0 70.5) 0.001
Therapy prior to surgery, n (%)
  β-blocker 1 (1.2) 1(100) 0 (0)
  ACEI 6 (7.1) 5 (7.5) 1 (5.9) 1.0
  Diuretics 32 (38.1) 21 (31.3) 11 (64.7) 0.011
  Digoxin 17 (20.2) 14 (20.9) 3 (17.6) 1.0
Surgical data
  Reconstruction of mitral valve, n (%) 41(48.8) 37 (55.2) 4 (23.5) 0.02
  Cardiopulmonary bypass, min, median (IQR) 111.0 (93.3, 138.5) 111.0 (92.0, 139.0) 109.0 (94.5, 142.5) 0.789
  Cardiopulmonary bypass ≥120 min, n (%) 32 (38.1) 24 (35.8) 8 (47.1) 0.394
  Crossclamp time, min, median (IQR) 69.0 (55.3, 86.0) 70.0 (57.0, 90.0) 67.0 (47.0, 82.0) 0.268
  1. PDC peritoneal dialysis catheter; LVEF left ventricular ejection fraction; LVEDD left ventricular end-diastolic diameter; CK-MB creatinine kinase-MB; ACEI angiotensin-converting enzyme inhibitors; IQR interquartile range; SD standard deviation